Cytosorbents Begin Period Cash Flow from 2010 to 2024
| CTSO Stock | USD 0.93 0.02 2.20% |
Begin Period Cash Flow | First Reported 2004-12-31 | Previous Quarter 8.4 M | Current Value 14.1 M | Quarterly Volatility 18.9 M |
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents Crp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 150 K or Selling General Administrative of 39.8 M, as well as many indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.002 or PTB Ratio of 2.24. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
Cytosorbents | Begin Period Cash Flow |
Latest Cytosorbents Crp's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Cytosorbents Crp over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Cytosorbents Crp's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Cytosorbents Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 15,479,819 | |
| Geometric Mean | 5,295,074 | |
| Coefficient Of Variation | 134.63 | |
| Mean Deviation | 14,624,392 | |
| Median | 5,316,851 | |
| Standard Deviation | 20,840,084 | |
| Sample Variance | 434.3T | |
| Range | 71.4M | |
| R-Value | 0.64 | |
| Mean Square Error | 275.9T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 2,984,575 | |
| Total Sum of Squares | 6080.3T |
Cytosorbents Begin Period Cash Flow History
About Cytosorbents Crp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cytosorbents Crp income statement, its balance sheet, and the statement of cash flows. Cytosorbents Crp investors use historical funamental indicators, such as Cytosorbents Crp's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Cytosorbents Crp investors may use each financial statement separately, they are all related. The changes in Cytosorbents Crp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytosorbents Crp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytosorbents Crp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytosorbents Crp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 22.1 M | 12.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Cytosorbents Stock
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:Check out the analysis of Cytosorbents Crp Correlation against competitors. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 0.776 | Quarterly Revenue Growth 0.036 | Return On Assets (0.33) | Return On Equity (1.15) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.